Protective Effect of Colostrum Therapy in Premature Infants Weighing Less Than 1500g at the INMP 2018-2021
Efecto protector de calostroterapia en prematuros menores de 1500g en el INMP 2018-2021 | 2018-2021 年 INMP 对 1500 克以下早产儿的初乳疗法保护作用
DOI:
https://doi.org/10.25176/RFMH.v24i4.6578Keywords:
Necrotizing enterocolitis, Newborn, neonate, calostrum, therapyAbstract
Background: Prematurity is a serious public health problem, due to its high morbidity and mortality, with 15 million premature births and one million deaths annually worldwide. The main causes of neonatal mortality in premature infants are necrotizing enterocolitis and late sepsis. In Peru, the percentage of premature births increased from 6.4% in 2020 to 7.5% in 2023, with an average of 30,000 premature newborns annually. In 2023, 70% of neonatal deaths corresponded to premature babies. The National Maternal Perinatal Institute reported high rates of neonatal mortality, especially in premature babies weighing less than 1500 grams. It is worth mentioning that of all neonatal deaths by 2023, 70% corresponded to premature babies and 46.5% to those less than 1500g.
Objective: Determine the protective effect of colostrotherapy in premature newborns with birth weight less than 1500g in the INMP during the period 2018-2021.
Methods: Longitudinal analytical observational and retrospective cohort study. The bivariate analysis was carried out, where the presence of the association between the variables and the administration of colostrotherapy was evidenced. In the multivariate analysis, 3 study models were proposed (model 1: necrotizing enterocolitis, model 2: requirement for mechanical ventilation and model 3: mortality), and Poisson-type multiple logistic regression was used, indicating the adjusted relative risk and its respective 95% confidence intervals.
Results: In the multivariate analysis, the 1st model showed that colostrotherapy (adjusted RR: 0.304, 95% CI: 0.099-0.93) acts as a protective factor against necrotizing enterocolitis. In the 2nd model, colostrotherapy showed no association with the requirement for mechanical ventilation. And finally, in the 3rd model it was shown that colostrotherapy (RR: 0.494, 95% CI: 0.32-0.76) acts as a protective effect with respect to mortality.
Conclusions: The administration of oropharyngeal colostrum is a simple and safe procedure, it can reduce the incidence of necrotizing enterocolitis and mortality in premature neonates less than 1500g.
Downloads
References
Guevara Ríos E. La prematuridad: Un problema de salud pública. Rev Peru Investig Matern Perinat 2022; 12(1): 7-8DOI https://doi.org/10.33421/inmp.2022334
Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Health. 2022;6(2):106-15. doi:10.1016/ S2352-4642(21)00311-4.
Panchal, H., G. Athalye-Jape, and S. Patole, Oropharyngeal Colostrum for Preterm Infants: A Systematic Review and Meta-Analysis. Adv Nutr, 2019. 10(6): p. 1152-1162. DOI: 10.1093/advances/nmz033.
MINSA. Repositorio Único Nacional de Información en Salud (REUNIS) (Consulta 25 de marzo del 2024). Registro Certificado de nacido vivo. Características del recién nacido. https://www.minsa.gob.pe/reunis/data/tablero_cnv.asp
MINSA. Centro nacional de Epidemiología, prevención y control de enfermedades CDC (Consulta 29 de marzo 2024). Sala virtual de muerte fetal y neonatal. https://www.dge.gob.pe/dashmnp/
Oficina de epidemiología y Salud ambiental - INMP. (2023). Boletin Epidemiologico semana 01al 52. Boletin Epidemiologico. (Consulta 29 de marzo 2024) https://www.inmp.gob.pe/institucional/boletin-epidemiologico/1421335605
Garofoli, F.; Civardi, E.; Pisoni, C.; Angelini, M.; Ghirardello, S. Anti-Inflammatory and Anti-Allergic Properties of Colostrum from Mothers of Full-Term and Preterm Babies: The Importance of Maternal Lactation in the First Days. Nutrients 2023, 15, 4249. https:// doi.org/10.3390/nu15194249
Sudeep, K.C., Kumar, J., Ray, S. et al. Oral Aplicación oral de calostro y leche materna a lactantes prematuros: un ensayo aleatorizado y 21 controlado. Indian 89, 579–586 (2022). https://doi.org/10.1007/s12098- 021-03982-4
Romero-Maldonado S, Soriano-Becerril DM, García-May PK, ReyesMuñoz E, Muñoz-Ortíz EG, Carrera-Muiños S, Granados-Cepeda ML, 22 Cardona-Pérez JA, Castro-Millán E, Segura-Cervantes E, Ceballos G, Montoya-Estrada A Efecto de la administración orofaríngea de calostro en recién nacidos prematuros ≤32 semanas de gestación sobre la respuesta inmune y la morbilidad neonatal: un ensayo clínico aleatorizado doble ciego. Front Pediatr. 2022 Jul 8;10:891491. doi: 10.3389/fped.2022.891491. PMID: 35874579; PMCID: PMC9304973.
Moreno J, Sanchez B, Serrano L, Martin E, Diaz J, Pena M, et al. Mejora de la respuesta inmunitaria a través de la administración de calostro por vía orofaringea en recién nacidos prematuros; 2019, Mar. 30(2): 234-241. Doi: 10.1111/pai.13008. Epub 2018 Dec 13. PMID: 30444546.eal%20colostrum.
Meier PP, Engstrom JL, Patel AL, Jegier BJ, Bruns NE. Improving the Use of Human Milk During and After the NICU Stay. Clin Perinatol 2010;37:217-45.
Gregory KE, Walker WA. Immunologic Factors in Human Milk and Disease Prevention in the Preterm Infant. Curr Pediatr Rep 2013;1(4):DOI:10.1007/ s40124-013-0028-2.
Huo M, Liu C, Mei H, Zhang Y, Liu C, Song D, et al. Efecto de la intervención de la administración orofaríngea de calostro en recién nacidos prematuros: un metanálisis. Pediatra frontal. 2022;10:895375.
Aggarwal R, Plakkal N, Bhat V. ¿La administración orofaríngea de calostro reduce la morbilidad y la mortalidad en recién nacidos muy prematuros? Un ensayo controlado aleatorio de grupos paralelos. J Pediatra Salud Infantil. 2021;57:1467-72.
De La Cruz Davila JPE, Munares Garcia OF. Asociación entre morbilidad materna extrema y sepsis en neonatos atendidos en el Instituto Nacional materno Perinatal, Lima 2016-2019. Rev Peru Investig Matern Perinat. 2021;10(2): 24-34DOI https://doi.org/10.33421/inmp.2021227
OuYang X, Yang CY, Xiu WL, Hu YH, Mei SS, Lin Q. Oropharyngeal administration of colostrum for preventing necrotizing enterocolitis and late-onset sepsis in preterm infants with gestational age ≤ 32 weeks: a pilot single-center randomized controlled trial. Int Breastfeed J [Internet]. 21 de agosto de 2021 [citado 25 de mayo de 2023];16:59. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379587/
Fu ZY, Huang C, Lei L, et al. The effect of oropharyngeal colostrum administration on the clinical outcomes of premature infants: A meta-analysis. Int J Nurs Stud. 2023;144:104527. doi:10.1016/j.ijnurstu.2023.104527
Sanchez, V., & Cisneros, L. (2020). FACTORES DE RIESGO DE ENTEROCOLITIS NECROTIZANTE EN RECIÉN NACIDOS MUY PREMATUROS, HOSPITAL VÍCTOR LAZARTE ECHEGARAY. Revista peruana de pediatria, 72, 59.
Tao J, Mao J, Yang J, Su Y. Effects of oropharyngeal administration of colostrum on the incidence of necrotizing enterocolitis, late-onset sepsis, and death in preterm infants: a meta-analysis of RCTs. Eur J Clin Nutr [Internet]. 2020 [citado 25 de mayo de 2023];74(8):1122-31. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222151/
Kumar J, Meena J, Ranjan A, Kumar P. Oropharyngeal application of colostrum or mother's own milk in preterm infants: a systematic review and meta-analysis. Nutr Rev. 2023;81(10):1254-1266. doi:10.1093/nutrit/nuad002
Slouha E, Anderson ZS, Ankrah NMN, Kalloo AE, Gorantla VR. Colostrum and Preterm Babies: A Systematic Review. Cureus. 2023;15(7):e42021. Published 2023 Jul 17. doi:10.7759/cureus.42021
Bashir T, Reddy KV, Kiran S, Murki S, Kulkarni D, Dinesh P. Effect of colostrum given within the 12 hours after birth on feeding outcome, morbidity and mortality in very low birth weight infants: a prospective cohort study. Sudan J Paediatr [Internet]. 2019 [citado 25 de mayo de 2023];19(1):19-24. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589796/
Martín E, Diaz J, Peña M, Serrano L, Moreno J, Sánchez-Martínez B, et al. Oropharyngeal Colostrum Positively Modulates the Inflammatory Response in Preterm Neonates. Nutrients [Internet]. 5 de febrero de 2020 [citado 6 de mayo de 2023];12(2):413. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32033312/
Maraboli Aguilera M, Lavanderos Bustamante G, León Martínez C, Zúñiga Ulloa M, Mena Nannig P. Evaluación de un protocolo de calostro para prematuros de muy bajo peso de nacimiento [Colostrum protocol evaluation for very low birth weight preterm infants]. Andes Pediatr. 2022;93(3):343-350. doi:10.32641/andespediatr.v93l3.3870
Abd-Elgawad M, Eldegla H, Khashaba M, Nasef N. Oropharyngeal Administration of Mother’s Milk Prior to Gavage Feeding in Preterm Infants: A Pilot Randomized Control Trial. JPEN J Parenter Enteral Nutr [Internet]. enero de 2020 [citado 6 de mayo de 2023];44(1):92-104. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31062377/
Snyder R, Herdt A, Mejias-Cepeda N, Ladino J, Crowley K, Levy P. Early provision of oropharyngeal colostrum leads to sustained breast milk feedings in preterm infants. Pediatr Neonatol [Internet]. diciembre de 2017 [citado 25 de mayo de 2023];58(6):534-40. Disponible en: https://pubmed.ncbi.nlm.nih.gov/28550982/
Lee J, Kim HS, Jung YH, Choi KY, Shin SH, Kim EK, et al. Oropharyngeal Colostrum Administration in Extremely Premature Infants: An RCT. Pediatrics [Internet]. 1 de febrero de 2015 [citado 25 de mayo de 2023];135(2):e357-66. Disponible en: https://doi.org/10.1542/peds.2014-2004
Romano-Keeler J, Azcarate-Peril MA, Weitkamp JH, Slaughter JC, McDonald WH, Meng S, et al. Oral colostrum priming shortens hospitalization without changing the immunomicrobial milieu. J Perinatol [Internet]. enero de 2017 [citado 25 de mayo de 2023];37(1):36-41. Disponible en: https://www.nature.com/articles/jp2016161
Nasuf AWA, Ojha S, Dorling J. Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev [Internet]. 7 de septiembre de 2018 [citado 25 de mayo de 2023];2018(9):CD011921. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513592/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista de la Facultad de Medicina Humana
This work is licensed under a Creative Commons Attribution 4.0 International License.
